自选
模拟交易
选股器
热力图
机构追踪

美股市场个股详情

BMRN 拜玛林制药

添加自选

70.730
-0.290-0.41%

交易中 03/04 09:46 (美东)

134.94亿总市值32.00市盈率TTM

关于拜玛林制药公司

拜玛林制药股份有限公司致力于为患有严重和危及生命的罕见疾病和医疗状况的人开发和商业化治疗。其管道产品包括valoccogene roxaparvovec, Vosoritide和BMN 307。

公司介绍

公司代码BMRN

公司名称拜玛林制药

上市日期1999/07/23

发行价格13.00

成立日期1997

CEOMr. Alexander Hardy

所属市场纳斯达克

员工数量3040

年结日12-31

公司地址770 Lindaro Street

城市San Rafael

省份加利福尼亚州

国家美国

邮编94901

电话1-415-506-6700

网址http://www.biomarin.com

董事高管

姓名
职务
年薪

Alexander Hardy
Director, President and Chief Executive Officer
1787.52万

Charles Greg Guyer
Chief Technical Officer and Executive Vice President
570.11万

G. Eric Davis
Executive Vice President, Chief Legal Officer and Secretary
--

Erin Burkhart
Group Vice President and Chief Accounting Officer
--

Dr. Greg Friberg
President, Chief Worldwide Research and Development Officer
--

Brian R. Mueller
Chief Financial Officer and Executive Vice President, Finance
485.42万

Richard A. Meier
Chairman of the Board
51.54万

Dr. Maykin Ho, PhD
Independent Director
47.39万

Barbara W. Bodem
Independent Director
21.34万

Robert J. Hombach
Independent Director
48.69万

David E.I. Pyott, M.B.A.,M.D.
Independent Director
47.04万

Dr. Elaine J. Heron,PhD
Independent Director
48.64万

Timothy P. Walbert
Independent Director
--

Dr. Willard H. Dere, M.D.
Independent Director
48.04万

Mark Joseph Enyedy
Independent Director
21.34万

Dr. Athena Countouriotis, M.D.
Independent Director
21.34万

Elizabeth McKee Anderson, M.B.A.
Independent Director
48.04万